LT - REDIRECTED, GENETICALLY-ENGINEERED T REGULATORY CELLS AND THEIR USE IN SUPPRESSION OF AUTOIMMUNE AND INFLAMMATORY DISEASE
EN - REDIRECTED, GENETICALLY-ENGINEERED T REGULATORY CELLS AND THEIR USE IN SUPPRESSION OF AUTOIMMUNE AND INFLAMMATORY DISEASE
Legal status
Patent not validated
Bibliographic data
Indications of the International Patent Classification (IPC)
(51) |
INT.CL. |
C12N 5/0783 |
(2010.01) |
|
|
A61K 39/0008 |
(2013.01) |
|
|
A61K 39/00 |
(2006.01) |
|
|
A61K 39/0011 |
(2013.01) |
|
|
A61P 29/00 |
(2006.01) |
|
|
C12N 5/0636 |
(2013.01) |
|
|
A61P 37/00 |
(2006.01) |
|
|
A61P 29/00 |
(2018.01) |
|
|
A61P 37/00 |
(2018.01) |
European patent
(11) |
Number of the document |
3097923 |
(13) |
Kind of document |
T |
(96) |
European patent application number |
16177278.5 |
|
Date of filing the European patent application |
2008-01-31 |
(97) |
Date of publication of the European application |
2016-11-30 |
(45) |
Date of publication and mention of the grant of the patent |
2022-07-27
|
(46) |
Date of publication of the claims translation |
|
Priority applications
(30) |
Number |
Date |
Country code |
|
898408 P |
2007-01-31
|
US |
|
951052 P |
2007-07-20
|
US |
Inventors
(72) |
ESHHAR, Zelig , IL
ELINAV, Eran , IL
|
Grantee
(73) |
YEDA RESEARCH AND
DEVELOPMENT CO., LTD. ,
The Weizmann Institute of Science,
P.O. Box 95, 76100 Rehovot,
IL
|
Title
(54) |
REDIRECTED, GENETICALLY-ENGINEERED T REGULATORY CELLS AND THEIR USE IN SUPPRESSION OF AUTOIMMUNE AND INFLAMMATORY DISEASE |
|
REDIRECTED, GENETICALLY-ENGINEERED T REGULATORY CELLS AND THEIR USE IN SUPPRESSION OF AUTOIMMUNE AND INFLAMMATORY DISEASE |